{
    "nctId": "NCT00899496",
    "briefTitle": "Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants",
    "officialTitle": "Pilot Study of Cancer Resistance in Humans",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "Cell killing ability (positive or negative)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n-Meets 1 of the following criteria:\n\n* Diagnosis of metastatic cancer including, but not limited to, any of the following:\n\n  * Stage IV non-small cell lung cancer\n  * Extensive-stage small cell lung cancer\n  * Metastatic testicular cancer\n  * Stage IV breast carcinoma\n  * Stage III or IV ovarian carcinoma\n  * Stage IV endometrial carcinoma\n  * Stage IV prostate carcinoma\n  * Stage IV colorectal or pancreatic cancer\n  * Stage IV renal cancer\n  * Stage III or IV non-Hodgkin's lymphoma\n  * Stage IV bladder cancer\n  * Stage III multiple myeloma (Salmon-Durie staging)\n  * Metastatic melanoma\n  * Metastatic sarcoma\n* Healthy participant, meeting the following criteria:\n\n  * No prior cancer\n  * Over 50 years of age\n\nExclusion Criteria:\n\n* Serious medical or psychiatric condition that would preclude study compliance\n* Chemotherapy or radiotherapy within the past 3 months (patient)\n* Prior immunosuppressive therapy or radiotherapy for any disease (healthy participant)",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}